HKPD: Hong Kong Pharma Digital Earnings per share for the last twelve months

HK Pharma Digital - graphic logo of issuer HKPD

Hong Kong Pharma Digital (HKPD) generates revenue through the digital distribution of pharmaceuticals and the servicing of pharmacies in Hong Kong. The company's unit profit over 12 months illustrates its financial stability, with the value of 0.00 serving as the current metric. This trend is driven by seamless integration with manufacturing plants, while growth is supported by the implementation of AI-driven predictive demand analysis models and cloud-based supply chain automation.

HKPD HK Pharma Digital Earnings per share for the last 12 months (01/16/2025 - 11/16/2026)

Analytical breakdowns for Hong Kong Pharma Digital (HKPD)

Analysis of all company metrics:HKPD - 9zt.hk
Flagship merchandise of HK Pharma Digital

Portfolio managers require an objective tool to assess the real return on capital. This indicator measures the rolling annual net income divided by the number of shares, neutralizing quarterly distortions. Analyzing the history of rolling earnings per share allows for the identification of how cost inflation impacts final margins. For Hong Kong Pharma Digital (HKPD), this metric confirms financial stability. The indispensability of digital pharmaceutical distribution in Asia ensures profit resilience regardless of macroeconomic cycles.